Protects the Nervous System: Research shows BPC-157 may protect brain neurons and help repair damage from traumatic injuries
The hexanoic side chain increases lipophilic character relative to unsubstituted peptide fragments
These observations suggest a potential role in reducing neurotoxin-related neural dysfunction within experimental settings (27)
Journal of PhysiologyPharmacology , 2007 This positions BPC-157 as a potential adjunct therapy for individuals with autoimmune gut disordersespecially those who haven't responded to conventional medications
In vitro studies suggest its mechanisms of action may be linked to reduction of LDL oxidation, or the ability of one of its constituents, luteolin, to indirectly inhibit HMG-CoA reductase
Before comparing them, one fact has to sit at the front: as of mid-2026, neither cagrilintide nor retatrutide is approved by the U.S